Our Gal Sal now calls UK home
What started as a three month long service leave adventure turned into five years, then another five years and now former local nurse Sally Lostroh calls the UK home...
Source: denipt.com.au
📰 Relapsing Remitting News
Page 2 - Relapsing Remitting News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relapsing Remitting. Real-time updates on events, politics, business and more.
EQS-News: Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug's Neuroprotective Potential
Issuer: Immunic, Inc. / Key word(s): Study results/Conference Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug’s Neuroprotective Potential 17.11.2022 / 12:30 CET/CEST The issuer is solely responsible for th...
Source: boersennews.de
MS Society disappointed with decision not to approve ozanimod
A CHARITY which represents people with MS has criticised a decision to deny approval of a new drug for treating the condition. The National Institute for Health and Care Excellence (NICE) - the regulator which approves new treatments and drugs for use by the NHS in England and Wales - has provisionally decided not to recommend ozanimod – a new, oral treatment for people with relapsing MS . The treatment would have been used to help those with relapsing multiple sclerosis. Oral treatme...
United Kingdom Teresa Attwood Ms Society Ms Society East Cumbria Group East Cumbria Group Relapsing Remitting
Source: newsandstar.co.uk